Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose study of remimazolam besylate for ICU sedation after noncardiac surgery
ChiCTR2000039343Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in agitation and None (6 arms), sponsored by Union Hospital. Primary endpoint: Effective dose of remimazolam besylate for sedation. Started Nov 2020; status: recruiting.
02
Drugs
remimazolam
03
Conditions
agitation
Beyond the preview
Go deeper on ChiCTR2000039343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039343.